Otros idiomas Nuformix plc

Acciones

Mercado cerrado - London S.E. Otros sitios de cotización 17:35:06 10/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,185 ^GBX	0,00 %		+5,71 %	-43,08 %

01/03	Nuformix anuncia una suscripción para recaudar 150.000 GBP	AN
15/01	Nuformix plc presenta los resultados de los dieciocho meses finalizados el 30 de septiembre de 2023	CI

Nuformix announces subscription to raise GBP150,000	01/03
Nuformix plc Reports Earnings Results for the Eighteen Months Ended September 30, 2023	15/01
Nuformix narrows annual loss as develops drug assets	03/01
Earnings Flash (NFX.L) NUFORMIX Reports FY23 Loss GBX-0.12	03/01
Nuformix plc Reports Earnings Results for the Half Year Ended September 30, 2023	03/01
Nuformix gets patent in Japan for pulmonary fibrosis treatment NXP002	23/10/23
Nuformix Receives Japanese Patent for Pulmonary Fibrosis Treatment; Shares Surge	23/10/23
Nuformix plc Announces Notice of Allowance of NXP002 Patent in Japan	23/10/23
Nuformix to fund its unlicensed programs with NXP001 windfall	05/10/23
Nuformix Updates Oxilio Agreement for NXP001	18/09/23
Nuformix to receive milestone payments from Oxilio pact	18/09/23
Nuformix plc Receives New NXP001 Development Milestone Payments in Updated Oxilio Agreement	18/09/23
Nuformix loss narrows; near-term goal to focus on NXP002 asset	22/05/23
Earnings Flash (NFX.L) NUFORMIX Posts FY23 EPS GBX0.11	22/05/23
Earnings Flash (NFX.L) NUFORMIX Posts Fiscal H1 EPS GBX0.11	22/05/23
Nuformix plc Reports Earnings Results for the Full Year Ended March 31, 2023	22/05/23
Nuformix says NXP002 shows anti-inflammatory effect	18/05/23
Nuformix to Launch Partnering Process for Inhaled Lung Disease Drug	18/05/23
Nuformix plc Announces Update Regarding the NXP002 Programme	18/05/23
FTSE 100 Inches Up as Market Awaits Key Inflation, Earnings Figures	17/04/23

No hay resultados para esta búsqueda